Jandhyala, Ravi http://orcid.org/0000-0002-7241-7476
Article History
Accepted: 30 November 2021
First Online: 7 January 2022
Declarations
:
: The author received no funding for this particular work.
: Ravi Jandhyala is a visiting senior lecturer at the Centre for Pharmaceutical Medicine Research at King’s College London, and is responsible for research into RWE approaches. He is also the Founder and CEO of Medialis Ltd, a medical affairs consultancy and contract research organization involved in the design and delivery of RWE, including patient-reported outcomes and patient registries.
: The study was approved by the King’s College Research Ethics Committee (reference number: MRA-20/21-22441).
: All study participants provided written consent to participate in this study.
: Not applicable.
: Medialis Ltd continues to support the Medical Affairs Pharmaceutical as part of its Corporate Social Responsibility Project.
: Data from this study will be made available upon reasonable request to the author.
: Not applicable.
: RJ conducted the study and prepared, authored, and approved the manuscript. He also designed and implemented the MAPPval instrument. He affirms that the manuscript is an honest, accurate, and transparent account of the study being reported, that no important aspects of the study have been omitted, and any discrepancies from the study as planned (and, if relevant, registered) have been explained.